Arteris, Inc.
595 Millich Dr. Suite 200
Campbell, CA 95008
November 30, 2022
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Jenny O’Shanick
| Re: | Arteris, Inc. |
Registration Statement on Form S-3
Filed November 9, 2022
File No. 333-268257
To the addressee set forth above:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (Registration No. 333-268257) (the “Registration Statement”) of Arteris, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Washington, D.C. time, on December 2, 2022, or as soon as practicable thereafter, or at such other time thereafter as our counsel, Latham & Watkins LLP may request by telephone. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Phillip Stoup at (415) 395-8216 or Tess Bloom at (415) 395-8897.
Thank you for your assistance in this matter.
| Very truly yours, | ||
| Arteris, Inc. | ||
| By: | /s/ K. Charles Janac | |
| K. Charles Janac | ||
| President and Chief Executive Officer | ||
| CC: | Nicholas B. Hawkins, Arteris, Inc. |
Jack Sheridan, Latham & Watkins LLP
Page Mailliard, Latham & Watkins LLP
Phillip S. Stoup, Latham & Watkins LLP